Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of Pediatric Hypertriglyceridemia Etiology: Insights from Next-Generation Sequencing Panels and Identification of Novel Variants. | Biochem Genet | 2026 | 40773003 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Approach to Identify and Investigate the Mechanisms of Active Components of Areca Catechu in Relation to Gut Disorders. | Acta Inform Med | 2025 | 41624471 | PubTator, text mining | PubMed |
| Naringin Mitigates PEDV-Induced Intestinal Damage in Suckling Piglets by Modulating Inflammatory, Antiviral, and Metabolic and Transport Pathways. | Biomolecules | 2025 | 41594589 | PubTator, text mining | PubMed |
| A real-world analysis of Lomitapide-associated adverse events: Data from FAERS and CVAROD. | Medicine (Baltimore) | 2025 | 41305759 | PubTator, text mining | PubMed |
| Primary Small Intestinal Epithelia Are Physiological Alternatives to the Caco-2 Lymphatic Transport Model. | Mol Pharm | 2025 | 41212758 | PubTator, text mining | PubMed |
| Lomitapide response in a cohort of patients with homozygous familial hypercholesterolemia and the potential influence of MTTP gene variants. | Orphanet J Rare Dis | 2025 | 41088305 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II. | Pharmaceuticals (Basel) | 2025 | 40872541 | PubTator, text mining | PubMed |
| Exome Sequencing in Adults with Unexplained Liver Disease: Diagnostic Yield and Clinical Impact. | Diagnostics (Basel) | 2025 | 40870862 | PubTator, text mining | PubMed |
| Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation. | J Pers Med | 2025 | 40863416 | PubTator, text mining | PubMed |
| Lipid homeostasis dysregulation in oral cancer drives metabolic reprogramming and offers novel diagnostic and therapeutic opportunities. | Discov Oncol | 2025 | 40853574 | PubTator, text mining | PubMed |
| Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. | JACC Case Rep | 2025 | 40846360 | PubTator, text mining | PubMed |
| Triglycerides and T Cells in Cardiovascular Risk: Inflammatory Transcriptomic Profile in Hypertriglyceridemia Patients' T Cells. | JACC Basic Transl Sci | 2025 | 40845480 | PubTator, text mining | PubMed |
| Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD. | Livers | 2025 | 40809813 | PubTator, text mining | PubMed |
| Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. | Sci Transl Med | 2025 | 40802740 | PubTator, text mining | PubMed |
| Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia. | Expert Opin Pharmacother | 2025 | 40779345 | PubTator, text mining | PubMed |
| Implementing a specialized cardiogenomics team for lipid disorders: Insights from a single large health system. | Am J Prev Cardiol | 2025 | 40761239 | PubTator, text mining | PubMed |
| Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndrome. | J Clin Lipidol | 2025 | 40500637 | PubTator, text mining | PubMed |
| Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data. | J Clin Lipidol | 2025 | 40494715 | PubTator, text mining | PubMed |
| DNMT1/MTTP axis promotes gastritis progression during Helicobacter pylori infection by regulating GPX4 and ferroptosis. | Epigenomics | 2025 | 40488428 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=3